Kemocarb 450MG Injection

Kemocarb 450mg Injection contains carboplatin, a platinum-based chemotherapy medicine widely used in the treatment of ovarian cancer, lung cancer, head and neck cancers, and various other solid tumors. Carboplatin works by damaging the DNA of cancer cells, preventing them from multiplying and slowing tumor growth. This makes Kemocarb Injection a crucial option in many oncological treatment protocols.

This anticancer injection is administered intravenously and must be given strictly under the supervision of a qualified oncologist in a hospital or oncology center. Kemocarb 450 mg Injection is often used as part of combination chemotherapy regimens to enhance effectiveness and improve treatment outcomes for patients with solid tumors.

Kemocarb 450 mg Injection meets international quality and safety requirements for chemotherapy medicines. It is suitable for hospital pharmacies, specialty oncology centers, and export supply. Kemocarb Injection offers a reliable and trusted option for managing advanced cancers when used as prescribed.

Product Features

• Platinum-based anticancer chemotherapy injection
• Contains Carboplatin 450 mg
• Used in multiple solid tumors
• Administered via IV infusion
• Lower nephrotoxicity compared to cisplatin
• Suitable for hospital and clinical oncology use
• Manufactured under GMP-compliant standards
• Prescription-required medicine

How It Helps

• Damages cancer cell DNA, preventing tumor growth and multiplication
• Effective against ovarian, lung, head & neck, and other solid tumors
• Lower nephrotoxicity compared to cisplatin for safer treatment
• Administered intravenously under the oncologist’s supervision for precise dosing